Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Wrobeln 2017 Artif Cells Nanomed Biotechnol

From Bioblast
Publications in the MiPMap
Wrobeln A, Schlüter KD, Linders J, Zähres M, Mayer C, Kirsch M, Ferenz KB (2017) Functionality of albumin-derived perfluorocarbon-based artificial oxygen carriers in the Langendorff-heart. Artif Cells Nanomed Biotechnol 45:723-30.

» PMID: 28278587 Open Access

Wrobeln A, Schlueter KD, Linders J, Zaehres M, Mayer C, Kirsch M, Ferenz KB (2017) Artif Cells Nanomed Biotechnol

Abstract: The aim of this study was to prove whether albumin-derived perfluorocarbon-based nanoparticles (capsules) can operate as a novel artificial oxygen carrier in a rat Langendorff-heart perfusion model. Hearts perfused with capsules showed increased left ventricular pressure and rate pressure product compared to hearts perfused with pure Krebs-Henseleit (KH)-buffer. The capsules prevented the myocardium from functional fail when in their absence a noxious ischemia was observed. Capsules did not change rheological properties of KH-buffer and could repeatedly reload with oxygen. This albumin-derived perfluorocarbon-based artificial oxygen carrier preserved the function of rat hearts due to the transport of oxygen in a satisfactory manner. Because of these positive results, the functionality of the applied capsules should be verified in living animals. Keywords: Langendorff-heart, Perfluorocarbon-based artificial oxygen carrier, Albumin, Blood substitutes, Nanocapsules, Perfluorodecalin Bioblast editor: Plangger M


Labels: MiParea: mt-Medicine, Pharmacology;toxicology 





HRR: Oxygraph-2k 

Labels, 2019-10